Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RFC and Rituximab Maintenance in Follicular Lymphoma
NCT01124526Phase 4Completed
- Sponsor
- Sociedad Española de Hematología y Hemoterapia
- Start
- Sep 2004
- Primary completion
- Jul 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of rituximab in follicular lymphoma (FL), sponsored by Sociedad Española de Hematología y Hemoterapia. Started Sep 2004; status: completed.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT01124526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01124526.